(Q46497558)

English

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

0 references

1 reference

based on heuristic

inferred from title

Acute myeloblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Nanri T

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Matsuno N

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Kawakita T

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Suzushima H

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Kawano F

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Mitsuya H

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

Asou N

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

19

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

1361-1366

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403803

0 references

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Disruption of differentiation in human cancer: AML shows the way.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

The roles of FLT3 in hematopoiesis and leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

The fifth immunoglobulin-like domain of the Kit receptor is required for proteolytic cleavage from the cell surface

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

Transcriptional repression of the p15 gene predicts the clinical outcome of acute myeloblastic leukemia with intermediate and adverse cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

21 January 2018

A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of c-kit gene integrity in aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403803

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403803

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15902284

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46497558&oldid=1534638526"